CAMEO+ eventCORPORATE2026-04-07🇺🇸
E2 raises $80M Series C to scale H15lo thrombectomy
source: Endovascular Engineering, Inc. (E2)
On 2026-04-07, Endovascular Engineering, Inc. (E2) announced an oversubscribed $80 million Series C financing round led by Gilde Healthcare and Norwest, with participation from existing and new strategic investors. The company said the capital will support scaling its Hēlo® thrombectomy platform and expanding commercial, regulatory, and customer success operations.
0.22Significance4.0Magnitude0.2Systemic0.3Market1Articles
Location
United StatesNorth AmericaUnited StatesNorth America39.828, -98.579
Story Links